article thumbnail

Former Biotech VC Steven Burrill Draws 30-Month Prison Term for Fraud

Xconomy

Steven Burrill, once a noted biotech investment fund founder, sought-after conference speaker, and life sciences publisher, was sentenced Wednesday to serve 30 months in federal prison for defrauding his investors and evading taxes. Burrill was indicted by a federal grand jury on September 14, 2017. Burrill was also charged.

article thumbnail

Organovo to Test “Patches” for Patients Awaiting Liver Transplants

Xconomy

The move represents a step toward a long-term goal that led to the formation of Organovo in 2007—of developing technology capable of bio-printing whole livers, kidneys, and other vital organs. The conference is making a webcast of his presentation available here. Reprints | Share:

San Diego 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Do Less. More.

Both Sides of the Table

There’s too much PR and too many tech blogs and too many newsletters and aggregators and Twitter summarizers to even try to catch everything that’s going on and equally there’s so much noise that it becomes harder to be heard. They simply said, with shrugged shoulders and without trying to make a big deal about it.

article thumbnail

Its BlogWorld Time! Los Angeles Get Ready!

Tech Zulu Event

Shani Higgins joined Technorati in 2007 to lead strategy and day to day operations for the company¹s advertising sales, business development and the Technorati Media advertising network. In 2006 he was named one of the most influential authorities on Blog Marketing in the world.

article thumbnail

Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug

Xconomy

Regulus was formed in September 2007 as a joint venture between Cambridge, MA-based Alnylam Pharmaceuticals (NASDAQ: ALNY ) and Carlsbad, CA-based Ionis Pharmaceuticals (NASDAQ: IONS ). Regulus is hosting a conference call this afternoon to discuss the news. The company went public in 2012 at $4 per share, but closed as high as $22.08

Study 52
article thumbnail

Interview: Lynda Weinman of Lynda.com

InfoChachkie

I would probably enjoy teaching, running a conference, making documentaries, curating a series of lectures, writing a book or a regular blog. Copyright © 2007-11 by J. I wish I had learned to delegate sooner, and to let go a little more. 1) I know that one of lynda.com’s current initiatives is corporate-wide training.

article thumbnail

Interview: Lynda Weinman of Lynda.com

InfoChachkie

I would probably enjoy teaching, running a conference, making documentaries, curating a series of lectures, writing a book or a regular blog. Copyright © 2007-11 by J. I wish I had learned to delegate sooner, and to let go a little more. 1) I know that one of lynda.com’s current initiatives is corporate-wide training.